MARKET

CMOPF

CMOPF

Cosmo Pharmaceuticals Nv
OTCPK
97.00
NaN%
Closed 09:30 04/07 EDT
OPEN
--
PREV CLOSE
97.00
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
162.00
52 WEEK LOW
55.00
MARKET CAP
1.58B
P/E (TTM)
-365.8997
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CMOPF last week (0330-0403)?
Weekly Report · 1d ago
Weekly Report: what happened at CMOPF last week (0323-0327)?
Weekly Report · 03/30 10:46
Kepler Capital Reaffirms Their Buy Rating on COSMO Pharmaceuticals N.V. (0RGI)
TipRanks · 03/28 01:36
Jefferies Keeps Their Buy Rating on COSMO Pharmaceuticals N.V. (0RGI)
TipRanks · 03/25 14:25
Weekly Report: what happened at CMOPF last week (0316-0320)?
Weekly Report · 03/23 10:41
Weekly Report: what happened at CMOPF last week (0309-0313)?
Weekly Report · 03/16 10:40
Cosmo to Showcase Real-Time Medical AI Platforms at NVIDIA GTC 2026
TipRanks · 03/16 06:33
Cosmo Highlights Leadership in Real Time Medical AI at NVIDIA GTC 2026
Newsfile · 03/16 06:09
More
About CMOPF
Cosmo Pharmaceuticals N.V. is a pharmaceutical company. The Company is focused on gastrointestinal (GI) diseases, dermatology, and healthtech. Its development pipeline includes Distal Ulcerative Colitis, Bile Acid Diarrhea, Solid Tumors, and AI Augmented Endoscopy. The Company's developed products include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, which is used for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, which is a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo, which is used for the treatment of travelers’ diarrhea (TD); Methylene Blue MMX, which is a diagnostic drug to improve precancerous and cancerous lesion detection during colonoscopy, and Winlevi, which is used for the treatment of acne. It also develops medical devices to assist with clinical decision-making.

Webull offers Cosmo Pharmaceuticals NV stock information, including OTCPK: CMOPF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CMOPF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CMOPF stock methods without spending real money on the virtual paper trading platform.